Evolving Role for BCMA-Targeted Therapies for MM

Source: Adapting Clinical Practice to a Rapidly Changing Therapeutic Landscape in Multiple Myeloma
Download Slideset
Download this slideset based on content from the annual CCO/IMF satellite symposium at ASH on BCMA-targeted treatment options for patients with relapsed/refractory multiple myeloma.
Thomas G. Martin, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 1.14 MB
Released: December 15, 2021

Acknowledgements

Provided by Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
Supported by educational grants from
Bristol-Myers Squibb
Genentech, a member of the Roche Group
GlaxoSmithKline
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
Karyopharm Therapeutics
Oncopeptides
Pfizer, Inc.
Sanofi Genzyme

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings